Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

August 2, 2024

Study Completion Date

August 8, 2025

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Omnipod 5 System

The Omnipod 5 system is a tubeless patch pump that receives glucose values and trend data from the glucose sensor every 5 minutes, automatically calculates insulin dose, and sends delivery commands to the Pod for the delivery of insulin.

Trial Locations (19)

Unknown

Cliniques Universitaires Saint-Luc, Brussels

Universitaire Ziekenhuizen Leuven, Leuven

Centre Hospitalier Universitaire Côte de Nacre, Caen

CHU Grenoble Aples, Grenoble

Hospices Civils de Lyon, Lyon

Hôpitaux Universitaires de Marseille Timone, Marseille

CHU de Nancy, Nancy

Hôpitaux Pédiatriques de Nice CHU-Lenval,, Nice

Centre Hospitalier Universitaire Carémeau de Nîmes, Nîmes

Hôpital Necker, Paris

Robert-Debré AP-HP Hospital, Paris

Centre Hospitalier Universitaire de Reims, Reims

CHU Rennes, Rennes

CHU Toulouse, Toulouse

University Hospitals of Derby & Burton, Derby

University Hospitals of Leicester NHS Trust, Leicester

Manchester University NHS Foundation Trust, Manchester

Mersey and West Lancashire NHS Teaching Hospitals Trust, Ormskirk

Oxford Health NHS Foundation Trust, Oxford

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT05923827 - Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults | Biotech Hunter | Biotech Hunter